Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022, Health News, ET HealthWorld
Gennova Biopharmaceuticals, subsidiary of Pune-based drugmaker Emcure which is developing mRNA Covid vaccine said it plans to finish the Phase 2/3 trials by January end next year and will seek…

